Microsaic Appoint New Chief Executive Officer
News Sep 25, 2012
Colin has nearly 30 years commercial and operational experience in the analytical instrumentation sector. He joins Microsaic from Shimadzu UK Ltd, a global manufacturer of scientific research instruments, where he spent the past 11 years as Managing Director. He was previously European Commercial Director at SGE Europe Ltd (1999-2001) and prior to that, he spent seven years in senior management and marketing positions at Mallinckrodt Baker in the UK and the Netherlands. Between 1983 and 1991 Colin served in sales and marketing positions at Bayer Diagnostics, Roche Diagnostics and Wellcome Diagnostics.
Colin will take up his role on 5th November 2012, at which point Eric Yeatman and Colin Nicholl will resume their former roles as Chairman and Deputy Chairman, respectively. The Board would like to acknowledge the roles both Eric and Colin have played over the past year in establishing the strong position for growth that the Company is in and look forward to their continued contributions in their Board capacities.
Commenting on the appointment, Eric Yeatman, Acting Chief Executive of Microsaic Systems plc, said:
“The Board is very pleased to welcome Colin Jump to the Company as our new CEO. I have no doubt his commercial and operational experience in the analytical instrumentation sector will help drive the business forward towards the further realisation of our corporate goals.”
Colin Jump added:
“I am excited to be joining Microsaic Systems at this crucial stage as it accelerates the commercialisation of its revolutionary chip-based technology. With the ability to address major opportunities across multiple market areas I see huge potential for the technology and for the Company in the years ahead.”
Changes Identified in Body Cells During Type2 Diabetes OnsetNews
Researchers have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes. Utilising metabolomics, results showed that amino acids play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE
Honey Bee Gut Metabolome Reveals How They Cope With a Pollen Rich DietNews
The honey bee gut is colonized by specialized bacteria that help digest components of the floral pollen diet and produce molecules that likely promote bee health. Researchers studied the metabolome from the bee gut and have uncovered which bacterial species perform which specific digestive functions.